Matches in Nanopublications for { ?s ?p "[These translocations are considered to dysregulate genes which may be concerned with myelomagenesis; i.e., PRAD1/cyclin D1, the c-myc oncogene, FGFR3 (fibroblast growth factor receptor 3), MMSET (multiple myeloma SET domain), MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4), and the c-maf oncogene, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP572309.RAJu0MDvZfzU8DxQdSf9hGlB2y5z5ppPuTWFH1ZTysKz8130_assertion description "[These translocations are considered to dysregulate genes which may be concerned with myelomagenesis; i.e., PRAD1/cyclin D1, the c-myc oncogene, FGFR3 (fibroblast growth factor receptor 3), MMSET (multiple myeloma SET domain), MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4), and the c-maf oncogene, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572309.RAJu0MDvZfzU8DxQdSf9hGlB2y5z5ppPuTWFH1ZTysKz8130_provenance.
- NP882111.RAHQSOTN-rbL6Mom2dIDZeMzE6WjMDqyFZmQMpmZyUoiw130_assertion description "[These translocations are considered to dysregulate genes which may be concerned with myelomagenesis; i.e., PRAD1/cyclin D1, the c-myc oncogene, FGFR3 (fibroblast growth factor receptor 3), MMSET (multiple myeloma SET domain), MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4), and the c-maf oncogene, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882111.RAHQSOTN-rbL6Mom2dIDZeMzE6WjMDqyFZmQMpmZyUoiw130_provenance.